Dr. Linda Shore-Lesserson, in her prospective study of cardiac surgery, showed a reduction in postoperative transfusion incidence of non-RBC blood products from 25% in the standard coagulation test-guided group to 5.6% in the TEG®-guided group.
Contact Us
© Copyright 1998 Haemoscope Corp. Thrombelastograph® and TEG® are registered trademarks of Haemoscope Corp.